Company: MDCXW
Filing Date: 2025-08-22
Form Type: 8-K
Source: 0001062993-25-014806
Chunk: 1

Company: Medicus Pharma Ltd.
Filing Date: 2025-08-22
Form: 8-K
Item: Item 3.02
Chunk 1
---
 Company in accordance with its requirements under the SEPA.

In addition, on August 13, 2025, James Quinlan, the Chief Financial Officer of the Company, exercised stock options to purchase 125,000 Common Shares for cash at an exercise price of $0.81 per Common Share and stock options to purchase 20,000 Common Shares for cash at an exercise price of $2.75 per Common Share, for aggregate proceeds to the Company of approximately $156,250. The Common Shares were issued and sold to Mr. Quinlan in reliance upon the exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act.

This report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Item 8.01. Other Events.